Viewing nowDapaslin Tablet 10mg (Dapagliflozin Propanediol Monohydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Korea United Pharm, Inc.

MFDS item code 202300341 · Approved 2023.01.26 · Insurance code 642803440
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps control blood sugar in patients with type 2 diabetes and assists with dietary and exercise regimens. It can be used alone or in combination with other medications. Caution is advised when used in patients with cardiovascular diseases or risk factors, especially if blood sugar is not adequately controlled. Detailed clinical information regarding this medication can be confirmed through a specialist. This medication is effectively used in the management of type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Children under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.
This medication should not be used in certain patients. Patients with allergies to the main ingredients or excipients, those with type 1 diabetes or diabetic ketoacidosis, patients with lactose-related genetic disorders, and patients undergoing dialysis should not receive this medication. Patients with decreased fluid volume or impaired kidney function should use this medication with caution. This drug may lower blood pressure or affect kidney function; thus, these patients should carefully monitor their physical condition before and during treatment. This medication contains specific dyes; patients with allergies or hypersensitivity to these dyes should take precautions. Various side effects may occur during treatment, including genital infections, urinary tract infections, hypoglycemia, fluid depletion, and ketoacidosis; if any unusual symptoms appear, immediate consultation with medical personnel is required. Particularly, symptoms of fluid depletion or low blood pressure may appear, necessitating special caution in patients at high risk of dehydration or hypotension. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, it should be discontinued immediately. The risk of hypoglycemia may increase when taken with other diuretics, insulin, sulfonylureas, etc.; therefore, dosage adjustments may be necessary. There is no specific antidote for overdose, and patients should receive treatment based on their condition; it is unknown whether this drug can be removed through dialysis. Finally, its safety and efficacy in children have not been sufficiently established, so it is advisable not to use it in pediatric patients.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. Additionally, it should be stored at room temperature, preferably between 1°C and 30°C, avoiding extremes of heat or cold.
Yellow, double convex, diamond-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.